MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) — Lobbying Disclosure | Poliscope

MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP)

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

—

Filings

Unique Clients

Active Period

1999–2026

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2026	—	3	1
2025	—	5	1
2024	—	4	1
2023	—	5	1
2022	—	6	1
2021	—	4	1
2020	—	5	1
2019	—	4	1
2018	—	5	1
2017	—	4	1
2016	—	4	1
2015	—	4	1
2014	—	5	1
2013	—	4	1
2012	—	4	1
2011	—	4	1
2010	—	4	1
2009	—	5	1
2008	—	4	1
2007	—	2	1
2006	—	2	1
2005	—	1	1
2004	—	1	1
2003	—	1	1
2000	—	2	1
1999	—	2	1

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS	—	94	1999–2026

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	94
SENATE	94
Health & Human Services, Dept of (HHS)	45
Centers For Medicare and Medicaid Services (CMS)	40
White House Office	10
Executive Office of the President (EOP)	7
Food & Drug Administration (FDA)	7
Office of Management & Budget (OMB)	3
Internal Revenue Service (IRS)	2
Treasury, Dept of	2
Federal Communications Commission (FCC)	1
Government Accountability Office (GAO)	1
Natl Economic Council (NEC)	1
Veterans Affairs, Dept of (VA)	1

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	94
Health Issues	Health Issues	94
Medicare/Medicaid	Medicare/Medicaid	94
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	80
Veterans	Veterans	46
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	33
Budget/Appropriations	Budget/Appropriations	7
Manufacturing	Manufacturing	6
Financial Institutions/Investments/Securities	Financial Institutions/Investments/Securities	4
Transportation	Transportation	2
Economics/Economic Development	Economics/Economic Development	2
Beverage Industry	Beverage Industry	2
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 1

H.R. 2120119th Congress

ROCR Value Based Program Act

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 2120

H.R. 2444119th Congress

Promoting Resilient Supply Chains Act of 2025

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 2444

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 2484

Show 21 more cited filings

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3164, Ensuring Community Access to Pharmacist Services Act.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 3164

H.R. 3514119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 3514

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 3521

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 4299

H.R. 879119th Congress

Medicare Patient Access and Practice Stabilization Act of 2025

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Client expense: $610,000 · Firm income: —

Matched citations: H.R. 879

S. 1816119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness.

Client expense: $610,000 · Firm income: —

Matched citations: S. 1816

S. 257119th Congress

Promoting Resilient Supply Chains Act of 2025

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains.

Client expense: $610,000 · Firm income: —

Matched citations: S.257

S. 3822119th Congress

Break Up Big Medicine Act

2026 · third_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $610,000 · Firm income: —

Matched citations: S. 3822

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 1

H.R. 2120119th Congress

ROCR Value Based Program Act

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 2120

H.R. 2444119th Congress

Promoting Resilient Supply Chains Act of 2025

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 2444

H.R. 2484119th Congress

Seniors’ Access to Critical Medications Act of 2025

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 2484

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3164, Ensuring Community Access to Pharmacist Services Act

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 3164

H.R. 3514119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 3514

H.R. 3521119th Congress

Clinical Trial Modernization Act

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 3521

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 4299

H.R. 879119th Congress

Medicare Patient Access and Practice Stabilization Act of 2025

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness

Client expense: $530,000 · Firm income: —

Matched citations: H.R. 879

S. 1816119th Congress

Improving Seniors’ Timely Access to Care Act of 2025

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2484, Seniors Access to Critical Medications Act of 2025 (Support: Allows medically integrated physician dispensing flexibilities); H.R. 879, Medicare Patient Access and Practice Stabilization Act of 2025 (Support: Increases provider reimbursement in the Physician Fee Schedule); H.R. 2120, ROCR Value Based Program Act (Support: Modifies Medicare payment system for radiation oncology services); S. 1816 H.R. 3514, Improving Seniors' Timely Access to Care Act of 2025 (Support: Streamlines prior authorization process); Medicare Physician Payment; Site Neutral Payment Reform; CY2026 Medicare Physician Fee Schedule Proposed Rule; Health Data, Artificial Intelligence, Interoperability and ePrior Authorization; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act of 2025 (Support: Provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation); PBM Transparency; Emergency Preparedness

Client expense: $530,000 · Firm income: —

Matched citations: S. 1816

S. 257119th Congress

Promoting Resilient Supply Chains Act of 2025

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 2444, Promoting Resilient Supply Chains Act; S.257, Promoting Resilient Supply Chains

Client expense: $530,000 · Firm income: —

Matched citations: S.257

S. 3822119th Congress

Break Up Big Medicine Act

2026 · second_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors); S. 3822, Break Up Big Medicine Act; Issues related to support for independent physician practices, community pharmacies, and community-based care; Drug Shortages; Safe Step Act (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $530,000 · Firm income: —

Matched citations: S. 3822

H.R. 1119th Congress

An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

2026 · first_quarter · Client: MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 3521, Clinical Trial Modernization Act; H.R. 1, One Big Beautiful Bill (Definition clarity around distributors);S. 3822, Break Up Big Medicine Act; Drug Shortages; Safe Step Act (not reintroduced in 119th) (Support establishing an exception to medication step-therapy protocol in specified cases).

Client expense: $860,000 · Firm income: —

Matched citations: H.R. 1

Source: Senate LDA